Yuchong Yang

3.0k total citations · 1 hit paper
50 papers, 2.3k citations indexed

About

Yuchong Yang is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yuchong Yang has authored 50 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 17 papers in Cancer Research. Recurrent topics in Yuchong Yang's work include Gastric Cancer Management and Outcomes (16 papers), Colorectal Cancer Treatments and Studies (10 papers) and Inflammatory Biomarkers in Disease Prognosis (8 papers). Yuchong Yang is often cited by papers focused on Gastric Cancer Management and Outcomes (16 papers), Colorectal Cancer Treatments and Studies (10 papers) and Inflammatory Biomarkers in Disease Prognosis (8 papers). Yuchong Yang collaborates with scholars based in China, United States and Belgium. Yuchong Yang's co-authors include Zhenning Wang, Yongxi Song, Xiaowan Chen, Junhua Zhao, Haiyang Zhang, Ting Deng, Yi Ba, Jingxu Sun, Tao Ning and Guoguang Ying and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Yuchong Yang

49 papers receiving 2.3k citations

Hit Papers

CAF secreted miR-522 suppresses ferroptosis and promotes ... 2020 2026 2022 2024 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer
    2020 776 citations Haiyang Zhang, Ting Deng et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuchong Yang China 18 1.2k 1.2k 733 719 370 50 2.3k
Eisuke Kobayashi Japan 28 1.1k 0.8× 780 0.6× 1.2k 1.7× 740 1.0× 296 0.8× 137 2.6k
Toshiya Ochiai Japan 26 868 0.7× 788 0.6× 702 1.0× 747 1.0× 733 2.0× 154 2.3k
Akira Tomokuni Japan 22 778 0.6× 745 0.6× 339 0.5× 570 0.8× 566 1.5× 93 1.8k
Fei Teng China 24 1.3k 1.1× 1.1k 0.9× 221 0.3× 472 0.7× 226 0.6× 107 2.4k
Tadafumi Asaoka Japan 27 802 0.6× 675 0.6× 317 0.4× 887 1.2× 786 2.1× 165 2.2k
Xianbiao Xie China 24 908 0.7× 656 0.5× 557 0.8× 303 0.4× 223 0.6× 81 1.6k
Hang Li China 27 864 0.7× 689 0.6× 1.9k 2.6× 1.2k 1.7× 236 0.6× 82 2.7k
Yanong Wang China 23 992 0.8× 800 0.7× 478 0.7× 339 0.5× 489 1.3× 54 1.8k
Junyu Long China 27 798 0.6× 750 0.6× 726 1.0× 781 1.1× 509 1.4× 82 2.0k

Countries citing papers authored by Yuchong Yang

Since Specialization
Citations

This map shows the geographic impact of Yuchong Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuchong Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuchong Yang more than expected).

Fields of papers citing papers by Yuchong Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuchong Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuchong Yang. The network helps show where Yuchong Yang may publish in the future.

Co-authorship network of co-authors of Yuchong Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuchong Yang. A scholar is included among the top collaborators of Yuchong Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuchong Yang. Yuchong Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Rui, Zhi Ji, Xia Wang, et al.. (2025). Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial. Nature Communications. 16(1). 1481–1481. 5 indexed citations
2.
Sun, Honggang, Gang Li, Haoran Zhao, Yuchong Yang, & Chunmiao Yuan. (2025). Effects of Different Safety Vent Bursting Pressures on Lithium-Ion Battery Thermal Runaway Process and Reaction Product Compositions. Energies. 18(5). 1173–1173. 3 indexed citations
3.
Li, Gang, et al.. (2024). Effects of carbonates on explosion characteristics of lithium-ion batteries venting gases. Fuel. 381. 133523–133523. 2 indexed citations
4.
Zhou, Wei, Haoran Zhao, Dejian Wu, et al.. (2024). Inhibition effect of inert gas jet on gas and hybrid explosions caused by thermal runaway of lithium-ion battery. Journal of Loss Prevention in the Process Industries. 90. 105336–105336. 13 indexed citations
5.
Ma, Juntao, Tao Wang, Yu Qiu, et al.. (2024). 52P Cadonilimab in combined with gemcitabine and cisplatin in advanced biliary tract cancer (BicureX): A phase II, single-arm clinical trial. Annals of Oncology. 35. S232–S232. 1 indexed citations
6.
Liu, Shaohua, et al.. (2024). Innovative approaches in imaging photoplethysmography for remote blood oxygen monitoring. Scientific Reports. 14(1). 19144–19144. 3 indexed citations
7.
8.
Duan, Jingjing, Yinghui Shi, Weixue Wang, et al.. (2024). Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study. BMC Cancer. 24(1). 302–302. 3 indexed citations
9.
10.
11.
Yang, Yuchong, Yao Lü, Ming Bai, et al.. (2023). The optimal time of starting adjuvant chemotherapy after curative surgery in patients with colorectal cancer. BMC Cancer. 23(1). 422–422. 10 indexed citations
12.
Huang, He, Ting Deng, Hao Chen, et al.. (2022). Gene Mutational Clusters in the Tumors of Colorectal Cancer Patients With a Family History of Cancer. Frontiers in Oncology. 12. 814397–814397. 2 indexed citations
13.
Song, Yongxi, Jingxu Sun, Junhua Zhao, et al.. (2021). Author Correction: Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion. Nature Communications. 12(1). 3149–3149. 7 indexed citations
14.
Yang, Haiou, Haiyang Zhang, Yuchong Yang, et al.. (2020). Hypoxia induced exosomal circRNA promotes metastasis of Colorectal Cancer via targeting GEF-H1/RhoA axis. Theranostics. 10(18). 8211–8226. 155 indexed citations
15.
Yu, Sun, Yongxi Song, Peng Gao, et al.. (2020). Prognostic Value of Preoperative Fibrinogen for Predicting Clinical Outcome in Patients with Nonmetastatic Colorectal Cancer. Cancer Management and Research. Volume 12. 13301–13309. 12 indexed citations
16.
Yang, Yuchong, Xuanzhang Huang, Likun Zhou, et al.. (2019). Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma. BMC Cancer. 19(1). 526–526. 48 indexed citations
17.
18.
Song, Yongxi, Jingxu Sun, Junhua Zhao, et al.. (2017). Non-coding RNAs participate in the regulatory network of CLDN4 via ceRNA mediated miRNA evasion. Nature Communications. 8(1). 289–289. 225 indexed citations
19.
Song, Yongxi, Yuchong Yang, Peng Gao, et al.. (2017). The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer. BMC Cancer. 17(1). 744–744. 64 indexed citations
20.
Zhao, Junhua, Jingxu Sun, Yongxi Song, et al.. (2015). A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion. Journal of Cancer Research and Clinical Oncology. 142(3). 601–609. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eisuke Kobayashi Breakdown of academic impact, for papers by Toshiya Ochiai Breakdown of academic impact, for papers by Akira Tomokuni Breakdown of academic impact, for papers by Fei Teng Breakdown of academic impact, for papers by Tadafumi Asaoka Breakdown of academic impact, for papers by Xianbiao Xie Breakdown of academic impact, for papers by Hang Li Breakdown of academic impact, for papers by Yanong Wang Breakdown of academic impact, for papers by Junyu Long
Rankless by CCL
2026